151 related articles for article (PubMed ID: 10204507)
1. Coagulation and fibrinolysis in children, adolescents, and young adults with inflammatory bowel disease.
Weber P; Husemann S; Vielhaber H; Zimmer KP; Nowak-Göttl U
J Pediatr Gastroenterol Nutr; 1999 Apr; 28(4):418-22. PubMed ID: 10204507
[TBL] [Abstract][Full Text] [Related]
2. Markers of coagulation and fibrinolysis as measures of disease activity in inflammatory bowel disease.
Kjeldsen J; Lassen JF; Brandslund I; Schaffalitzky de Muckadell OB
Scand J Gastroenterol; 1998 Jun; 33(6):637-43. PubMed ID: 9669637
[TBL] [Abstract][Full Text] [Related]
3. Prothrombin fragment 1 + 2 and thrombin-antithrombin III complex as markers of activation of blood coagulation in inflammatory bowel diseases.
Chamouard P; Grunebaum L; Wiesel ML; Frey PL; Wittersheim C; Sapin R; Baumann R; Cazenave JP
Eur J Gastroenterol Hepatol; 1995 Dec; 7(12):1183-8. PubMed ID: 8789309
[TBL] [Abstract][Full Text] [Related]
4. Continuous active state of coagulation system in patients with nonthrombotic inflammatory bowel disease.
Alkim H; Ayaz S; Alkim C; Ulker A; Sahin B
Clin Appl Thromb Hemost; 2011; 17(6):600-4. PubMed ID: 21593018
[TBL] [Abstract][Full Text] [Related]
5. Coagulation and fibrinolysis in inflammatory bowel disease and in giant cell arteritis.
Vrij AA; Rijken J; van Wersch JW; Stockbrügger RW
Pathophysiol Haemost Thromb; 2003; 33(2):75-83. PubMed ID: 14624048
[TBL] [Abstract][Full Text] [Related]
6. Disturbed fibrinolysis in patients with inflammatory bowel disease. A study in blood plasma, colon mucosa, and faeces.
de Jong E; Porte RJ; Knot EA; Verheijen JH; Dees J
Gut; 1989 Feb; 30(2):188-94. PubMed ID: 2495239
[TBL] [Abstract][Full Text] [Related]
7. Determination of prothrombin activation fragments in young patients with inflammatory bowel disease.
Smith CJ; Haire WD; Kaufman SS; Mack DR
Am J Gastroenterol; 1996 Jun; 91(6):1221-5. PubMed ID: 8651175
[TBL] [Abstract][Full Text] [Related]
8. Studies on blood coagulation in ulcerative colitis and Crohn's disease.
Mori K; Watanabe H; Hiwatashi N; Sugai K; Goto Y
Tohoku J Exp Med; 1980 Sep; 132(1):93-101. PubMed ID: 7209972
[TBL] [Abstract][Full Text] [Related]
9. Elevated markers of thrombin generation and fibrinolysis in patients with active and quiescent ulcerative colitis.
Zezos P; Papaioannou G; Nikolaidis N; Patsiaoura K; Vassiliadis T; Mpoumponaris A; Giouleme O; Evgenidis N
Med Sci Monit; 2009 Nov; 15(11):CR563-72. PubMed ID: 19865055
[TBL] [Abstract][Full Text] [Related]
10. Activations of coagulation and fibrinolysis secondary to bowel inflammation in patients with ulcerative colitis.
Kume K; Yamasaki M; Tashiro M; Yoshikawa I; Otsuki M
Intern Med; 2007; 46(17):1323-9. PubMed ID: 17827828
[TBL] [Abstract][Full Text] [Related]
11. Changes in coagulation and hemodynamics during pregnancy: a prospective longitudinal study of 58 cases.
Hui C; Lili M; Libin C; Rui Z; Fang G; Ling G; Jianping Z
Arch Gynecol Obstet; 2012 May; 285(5):1231-6. PubMed ID: 22083312
[TBL] [Abstract][Full Text] [Related]
12. Hemostatic abnormalities in inflammatory bowel disease.
Chiarantini E; Valanzano R; Liotta AA; Cellai AP; Fedi S; Ilari I; Prisco D; Tonelli F; Abbate R
Thromb Res; 1996 Apr; 82(2):137-46. PubMed ID: 9163067
[TBL] [Abstract][Full Text] [Related]
13. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.
Van Geet C; Proesmans W; Arnout J; Vermylen J; Declerck PJ
Kidney Int; 1998 Oct; 54(4):1324-30. PubMed ID: 9767551
[TBL] [Abstract][Full Text] [Related]
14. Evidence for activation of coagulation in Crohn's disease.
Hudson M; Hutton RA; Wakefield AJ; Sawyerr AM; Pounder RE
Blood Coagul Fibrinolysis; 1992 Dec; 3(6):773-8. PubMed ID: 1489898
[TBL] [Abstract][Full Text] [Related]
15. Coagulation studies in ulcerative colitis and Crohn's disease.
Lam A; Borda IT; Inwood MJ; Thomson S
Gastroenterology; 1975 Feb; 68(2):245-51. PubMed ID: 1116673
[TBL] [Abstract][Full Text] [Related]
16. Plasma thrombin-activatable fibrinolysis inhibitor and plasminogen activator inhibitor-1 levels in inflammatory bowel disease.
Koutroubakis IE; Sfiridaki A; Tsiolakidou G; Coucoutsi C; Theodoropoulou A; Kouroumalis EA
Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):912-6. PubMed ID: 18794606
[TBL] [Abstract][Full Text] [Related]
17. Elevated serum levels and reduced immunohistochemical expression of thrombomodulin in active ulcerative colitis.
Boehme MW; Autschbach F; Zuna I; Scherbaum WA; Stange E; Raeth U; Sieg A; Stremmel W
Gastroenterology; 1997 Jul; 113(1):107-17. PubMed ID: 9207268
[TBL] [Abstract][Full Text] [Related]
18. Association between enhanced soluble CD40 ligand and prothrombotic state in inflammatory bowel disease.
Koutroubakis IE; Theodoropoulou A; Xidakis C; Sfiridaki A; Notas G; Kolios G; Kouroumalis EA
Eur J Gastroenterol Hepatol; 2004 Nov; 16(11):1147-52. PubMed ID: 15489574
[TBL] [Abstract][Full Text] [Related]
19. No evidence for a prethrombotic state in stable chronic inflammatory bowel disease.
Knot E; Ten Cate JW; Leeksma OC; Tytgat GN; Vreeken J
J Clin Pathol; 1983 Dec; 36(12):1387-90. PubMed ID: 6655071
[TBL] [Abstract][Full Text] [Related]
20. Fibrinolysis, antithrombin III, and protein C in neonates during cardiac operations.
Petăjă J; Peltola K; Sairanen H; Leijala M; Kekomäki R; Vahtera E; Siimes MA
J Thorac Cardiovasc Surg; 1996 Sep; 112(3):665-71. PubMed ID: 8800154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]